Citations

Clear

4 citation(s) found for "Schwartz, Joel".

Point of care molecular cancer diagnostics
Bhaskar, Seemesh , Umrao, Saurabh , Lee, Han Keun , Tibbs, Joseph , Bacon, Amanda , Shepherd, Skye , Ayupova, Takhmina , Ciloglu, Fatma Uysal , Liu, Leyang , Tan, Anqi , Chen, Wang-Chien , Nguyen, My Thi Tra , Scannell, Maria Grace , Aygün, Uğur , Zhang, Catherine, Adami, Guy R. , Badar, Wali, Gaba, Ron C. , Mansfield, A., Schwartz, Joel L., XING, WANG, Demirci, Utkan, Parlatan, Ugur , Zhang, Catherine , Kohli, Manish , Adami, Guy R , Badar, Wali , Gaba, Ron C , Mansfield, Aaron S , Schwartz, Joel , Xing, Wang , Demirci, Utkan , Cunningham, Brian T , Kohli, Manish , Mansfield, Aaron S. , Demirci, Utkan , Cunningham, Brian T.

Mayo Clinic

Lab on a Chip | February 10, 2026 | Volume: 26 | Issue: 10 | Pages: 2948-3001

10.1039/d5lc01014d | PMID 41811171 Get It

Convergent framework for future POC cancer diagnostics aligning clinical needs (why), enabling technologies (how), and translational bridges. It integrates lab-on-chip biosensing and analytics for decentralized, early, longitudinal care.
DNA Methylation of Telomere-Related Genes and Cancer Risk
Joyce, Brian , Zheng, Yinan , Nannini, Drew R. , Zhang, Zhou , Gao, Tao , Kocherginsky, Masha , Murphy, Robert L. , Yang, Hushan , Achenbach, Chad J. , Roberts, Lewis R. , Hoxha, Mirjam , Shen, Jincheng , Vokonas, Pantel , Schwartz, Joel , Hou, Lifang , Murphy, Robert , Roberts, Lewis R , Liu, Lei , Baccarelli, Andrea , Zheng, Yinan , Hou, Lifang

Mayo Clinic

Cancer Prevention Research | June 12, 2018 | Volume: 11 | Issue: 8 | Pages: 511-522

10.1158/1940-6207.capr-17-0413 | PMID 29895583 Get It

Abstract Researchers hypothesized that telomere shortening facilitates carcinogenesis. Previous studies found inconsistent associations between blood leukocyte telomere length (LTL) and cancer. Epigenetic reprogramming of telomere maintenance mechanisms may help explain this inconsistency. We examined associations between DNA methylation in telomere-related genes (TRG) and cancer. We analyzed 475 participants providing 889 samples 1 to 3 times (median follow-up, 10.1 years) from 1999 to 2013 in the Normative Aging Study. All participants were cancer-free at each visit and blood leukocytes profiled using the Illumina 450K array. Of 121 participants who developed cancer, 34 had prostate cancer, 10 melanoma, 34 unknown skin malignancies, and 43 another cancer. We examined 2,651 CpGs from 80 TRGs and applied a combination of Cox and mixed models to identify CpGs prospectively associated with cancer (at FDR < 0.05). We also explored trajectories of DNA methylation, logistic regression stratified by time to diagnosis/censoring, and cross-sectional models of LTL at first blood draw. We identified 30 CpGs on 23 TRGs whose methylation was positively associated with cancer incidence (β = 1.0–6.93) and one protective CpG in MAD1L1 (β = −0.65), of which 87% were located in TRG promoters. Methylation trajectories of 21 CpGs increased in cancer cases relative to controls; at 4 to 8 years prediagnosis/censoring, 17 CpGs were positively associated with cancer. Three CpGs were cross-sectionally associated with LTL. TRG methylation may be a mechanism through which LTL dynamics reflect cancer risk. Future research should confirm these findings and explore potential mechanisms underlying these findings, including telomere maintenance and DNA repair dysfunction. Cancer Prev Res; 11(8); 511–22. ©2018 AACR.
Cyclic 3',5'-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells
Yamaki, M., McIntyre, Steven J., Rassier, Mark E., Schwartz, Joel H., Douša, Thomas P.

Mayo Clinic

American Journal of Physiology-Renal Physiology | December 23, 2017 | Volume: 262 | Issue: 6 | Pages: F957-F964

10.1152/ajprenal.1992.262.6.f957 | PMID 1320333 Get It

We studied cyclic 3',5'-nucleotide phosphodiesterase (PDE) isozymes and their role in adenosine 3',5'-cyclic monophosphate (cAMP) and cGMP metabolism in a rat inner medullary collecting duct (IMCD) cell line. The homogenized and fractionated IMCD cells of cAMP-PDE and all of cGMP-PDE activity were found in the cytosol. The majority of cytosolic cAMP-PDE (greater than 50%) was isozyme PDE-IV; the Ca(2+)-calmodulin-sensitive PDE-I was present only in cytosol. Preincubation of IMCD cells with PDE-IV inhibitor rolipram markedly (5x) enhanced levels of cAMP both basal and in the presence of [Arg8]vasopressin (AVP). Cilostamide (for PDE-III) or vinpocetine had no effect, whereas PDE-I inhibitor 8-methoxymethyl-3-isobutyl-1-methylxanthine (8-MeoM-IBMX) enhanced AVP-dependent cAMP levels. Exposure of IMCD cells to 2 microM ionomycin decreased both basal and AVP-stimulated cAMP. Depletion of Ca2+ by preincubation of IMCD cells in the Ca(2+)-free medium with ethylene glycol-bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid markedly enhanced the stimulatory response of cAMP to AVP, and addition of 8-MeoM-IBMX further enhanced the AVP response. The levels of cGMP, basal or in response to atriopeptin (ANP), were not affected by PDE-V inhibitor zaprinast, but both inhibitors of PDE-I, 8-MeoM-IBMX and vinpocetine, increased basal cGMP, and 8-MeoM-IBMX also increased cGMP levels enhanced by ANP. The depletion of Ca2+ from IMCD cells alone had no effect on cGMP levels, but effects of 8-MeoM-IBMX and vinpocetine on the ANP-stimulated cGMP levels were enhanced.(ABSTRACT TRUNCATED AT 250 WORDS)
CpGFilter: model-based CpG probe filtering with replicates for epigenome-wide association studies
Chen, Jun , Just, Allan C. , Schwartz, Joel , Hou, Lifang , Jafari, Nadereh, Sun, Zhifu , Kocher, Jean‐Pierre , Baccarelli, Andrea , Lin, Xihong , Sun, Zhifu , Hou, Lifang

Mayo Clinic

Bioinformatics | October 9, 2015 | Volume: 32 | Issue: 3 | Pages: 469-471

10.1093/bioinformatics/btv577 | PMID 26449931 Get It

Abstract Summary: The development of the Infinium HumanMethylation450 BeadChip enables epigenome-wide association studies at a reduced cost. One observation of the 450K data is that many CpG sites the beadchip interrogates have very large measurement errors. Including these noisy CpGs will decrease the statistical power of detecting relevant associations due to multiple testing correction. We propose to use intra-class correlation coefficient (ICC), which characterizes the relative contribution of the biological variability to the total variability, to filter CpGs when technical replicates are available. We estimate the ICC based on a linear mixed effects model by pooling all the samples instead of using the technical replicates only. An ultra-fast algorithm has been developed to address the computational complexity and CpG filtering can be completed in minutes on a desktop computer for a 450K data set of over 1000 samples. Our method is very flexible and can accommodate any replicate design. Simulations and a real data application demonstrate that our whole-sample ICC method performs better than replicate-sample ICC or variance-based method. Availability and implementation: CpGFilter is implemented in R and publicly available under CRAN via the R package ‘CpGFilter’. Contact: chen.jun2@mayo.edu or xlin@hsph.harvard.edu Supplementary information: Supplementary data are available at Bioinformatics online.